affect from a government adopting a more restrictive lockdown measures in dark-red zones and uncertainty surrounding the COVID-19 situation that will hinge mainly on the rollout of vaccines in order to

approved by the Board of Directors. From the nine-month operations, the Company had a net loss of 96.03 million baht in which there is a loss attributable for the equity holders of the Company of 102.81

statements for the third quarter ended 30th September 2018 which was duly approved by the Board of Directors. From the nine-month operations, the Company had a net loss of 47.58 million baht in which there is

33% EBITDA 83 103 24% 306 391 28% Net Profit (Loss) for the Company 36 47 31% 118 178 51% Gross Profit Margin (%) 62.9% 65.0% 2.1% 63.1% 64.8% 1.7% EBITDA Margin1 (%) 30.7% 32.1% 1.3% 32.1% 31.8% (0.3

of Directors. From the six-month operations, the Company had a net loss of 70.37 million baht in which there is a loss attributable for the equity holders of the Company of 75.76 million baht and the

31st December 2017 resulted in the Company net loss of 204.80 million baht in which there is a loss attributable for the equity holders of the Company of 209.38 million baht. The net loss includes loss

had a net loss of 34.71 million baht in which there is a loss attributable for the equity holders of the Company of 34.72 million baht and the net loss includes an unrealized gain on foreign exchange of

had a net loss of 39.98 million baht in which there is a loss attributable for the equity holders of the Company of 38.85 million baht and the net loss includes unrealized loss on foreign exchange of

Income for the year 2019 per following table: (THB) Million 2019 2018 Change %Change Total Revenues 531.73 538.96 (7.23) (1) Total Expenses (497.06) (488.86) 8.20 2 Shares of Profits (Loss) (46.23) 26.72